397 related articles for article (PubMed ID: 12183331)
1. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels.
Akerman S; Williamson DJ; Kaube H; Goadsby PJ
Br J Pharmacol; 2002 Sep; 137(1):62-8. PubMed ID: 12183331
[TBL] [Abstract][Full Text] [Related]
2. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
Akerman S; Goadsby PJ
Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
[TBL] [Abstract][Full Text] [Related]
3. The role of histamine in dural vessel dilation.
Akerman S; Williamson DJ; Kaube H; Goadsby PJ
Brain Res; 2002 Nov; 956(1):96-102. PubMed ID: 12426051
[TBL] [Abstract][Full Text] [Related]
4. Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats.
Williamson DJ; Shepheard SL; Cook DA; Hargreaves RJ; Hill RG; Cumberbatch MJ
Br J Pharmacol; 2001 Jul; 133(6):807-14. PubMed ID: 11454653
[TBL] [Abstract][Full Text] [Related]
5. The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels.
Akerman S; Williamson DJ; Kaube H; Goadsby PJ
Eur J Pharmacol; 2002 Oct; 452(2):223-8. PubMed ID: 12354573
[TBL] [Abstract][Full Text] [Related]
6. Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation.
Andreou AP; Holland PR; Goadsby PJ
Br J Pharmacol; 2009 Jun; 157(3):464-73. PubMed ID: 19309356
[TBL] [Abstract][Full Text] [Related]
7. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation.
Akerman S; Kaube H; Goadsby PJ
Br J Pharmacol; 2003 Oct; 140(4):718-24. PubMed ID: 14534154
[TBL] [Abstract][Full Text] [Related]
8. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.
Akerman S; Williamson DJ; Goadsby PJ
Br J Pharmacol; 2003 Oct; 140(3):558-66. PubMed ID: 12970082
[TBL] [Abstract][Full Text] [Related]
9. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors.
Akerman S; Kaube H; Goadsby PJ
Br J Pharmacol; 2004 Aug; 142(8):1354-60. PubMed ID: 15277315
[TBL] [Abstract][Full Text] [Related]
10. Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery.
Bhatt DK; Ploug KB; Ramachandran R; Olesen J; Gupta S
Headache; 2010 Jun; 50(6):1017-30. PubMed ID: 20487037
[TBL] [Abstract][Full Text] [Related]
11. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
12. Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat.
Messlinger K; Suzuki A; Pawlak M; Zehnter A; Schmidt RF
Br J Pharmacol; 2000 Apr; 129(7):1397-404. PubMed ID: 10742295
[TBL] [Abstract][Full Text] [Related]
13. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist.
Cumberbatch MJ; Williamson DJ; Mason GS; Hill RG; Hargreaves RJ
Br J Pharmacol; 1999 Mar; 126(6):1478-86. PubMed ID: 10217543
[TBL] [Abstract][Full Text] [Related]
14. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.
De Felice M; Ossipov MH; Wang R; Dussor G; Lai J; Meng ID; Chichorro J; Andrews JS; Rakhit S; Maddaford S; Dodick D; Porreca F
Brain; 2010 Aug; 133(Pt 8):2475-88. PubMed ID: 20627971
[TBL] [Abstract][Full Text] [Related]
15. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle.
Gocan NC; Scott JA; Tyml K
Am J Physiol Heart Circ Physiol; 2000 May; 278(5):H1480-9. PubMed ID: 10775125
[TBL] [Abstract][Full Text] [Related]
17. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
[TBL] [Abstract][Full Text] [Related]
18. Involvement of capsaicin-sensitive afferent nerves in the proteinase-activated receptor 2-mediated vasodilatation in the rat dura mater.
Dux M; Rosta J; Sántha P; Jancsó G
Neuroscience; 2009 Jul; 161(3):887-94. PubMed ID: 19362118
[TBL] [Abstract][Full Text] [Related]
19. Vasorelaxations induced by calcitonin gene-related peptide, vasoactive intestinal peptide, and acetylcholine in aortic rings of endothelial and inducible nitric oxide synthase-knockout mice.
Chan SL; Fiscus RR
J Cardiovasc Pharmacol; 2003 Mar; 41(3):434-43. PubMed ID: 12605022
[TBL] [Abstract][Full Text] [Related]
20. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception.
Akerman S; Kaube H; Goadsby PJ
J Pharmacol Exp Ther; 2004 Apr; 309(1):56-63. PubMed ID: 14718591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
